AGFG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.957000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.097600E-01
Normal-vs-Stage2
8.915200E-01
Normal-vs-Stage3
3.251400E-01
Normal-vs-Stage4
3.416600E-01
Stage1-vs-Stage2
2.353600E-01
Stage1-vs-Stage3
8.365200E-01
Stage1-vs-Stage4
8.972100E-02
Stage2-vs-Stage3
2.405600E-01
Stage2-vs-Stage4
3.356600E-01
Stage3-vs-Stage4
1.011790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.482200E-01
Normal-vs-AfricanAmerican
7.285000E-01
Normal-vs-Asian
8.263600E-01
Caucasian-vs-AfricanAmerican
3.936600E-01
Caucasian-vs-Asian
4.907600E-01
AfricanAmerican-vs-Asian
8.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.465200E-01
Normal-vs-Female
9.402000E-01
Male-vs-Female
5.899800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.285800E-01
Normal-vs-Age(41-60Yrs)
6.648400E-01
Normal-vs-Age(61-80Yrs)
8.969000E-01
Normal-vs-Age(81-100Yrs)
4.865400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.394200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.993600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.722600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.522500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.902400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.792800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.988800E-01
Normal-vs-Daily Drinker
4.381800E-01
Normal-vs-Weekly Drinker
9.016200E-01
Normal-vs-Occasional Drinker
6.138200E-01
Normal-vs-Social Drinker
8.371600E-01
Non Drinker-vs-Daily Drinker
5.862200E-01
Non Drinker-vs-Weekly Drinker
5.063800E-01
Non Drinker-vs-Occasional Drinker
4.470300E-02
Non Drinker-vs-Social Drinker
5.886800E-01
Daily Drinker-vs-Weekly Drinker
2.956600E-01
Daily Drinker-vs-Occasional Drinker
1.956040E-02
Daily Drinker-vs-Social Drinker
3.426400E-01
Weekly Drinker-vs-Occasional Drinker
3.090200E-01
Weekly Drinker-vs-Social Drinker
9.047000E-01
Occasional Drinker-vs-Social Drinker
2.332000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.372170E-01
Normal-vs-Grade 2
1.521620E-02
Normal-vs-Grade 3
6.415400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.878500E-03
Grade 1-vs-Grade 3
8.801200E-03
Grade 1-vs-Grade 4
1.372170E-01
Grade 2-vs-Grade 3
9.666400E-01
Grade 2-vs-Grade 4
1.521620E-02
Grade 3-vs-Grade 4
6.415400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.649600E-01
Normal-vs-NonDiabetic
8.974200E-01
Diabetic-vs-NonDiabetic
8.099400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.734400E-01
Normal-vs-NoPancreatitis
9.242400E-01
Pancreatitis-vs-NoPancreatitis
7.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.768800E-01
Normal-vs-N1
9.224600E-01
N0-vs-N1
3.976800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.935600E-01
Normal-vs-TP53-NonMutant
7.198800E-01
TP53-Mutant-vs-TP53-NonMutant
1.388410E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
